Pfizer faces another year of revenue decline in 2026, as Covid and loss-of-exclusivity headwinds weigh on top line growth.
With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...
As the year ends, The 19th takes a look at how the conservative policy wishlist for President Donald Trump’s second term ...
As the extraordinary revenue phase driven by COVID-19 vaccines recedes, BioNTech is executing a deliberate strategic realignment. The company's recent moves— ...
There was more good health news about the COVID-19 vaccine for infants, kids and adults in December. There’s still time to ...
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
An analysis by The Marshall Project provides a window into what causes thousands of people to die in prisons and jails every ...
Austin-Bergstrom International Airport tops the list with 182 elevator rescues since 2022. Half the list consists of West ...
A black-box warning is not a neutral informational update. It is the FDA’s most aggressive regulatory communication via product labeling, intended to alert clinicians and patients to risks so grave ...
A new report found that gaps in data on juvenile justice in Baltimore make it “challenging — if not impossible — to track and ...
For more than half a century, Related Companies has built the communities and infrastructure that keeps our cities growing and resilient. Today, that same spirit of innovation is driving us forward as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback